UNSPSC 51361900: Hypnotic barbiturates

Hypnotic drugs made from a class of chemicals derived from barbituric acid or thiobarbituric acid.

UNSPSC 51361900 Hypnotic barbiturates is a Class code that does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities solicited pharmaceuticals and drug-related products — naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals with OTC products — none of which fall within the scope of hypnotic barbiturates as a drug category. The code shows little relevant recent activity; the mismatch suggests either miscoding in the state and local procurement systems or that hypnotic barbiturates themselves are not being actively solicited through public notices at present.

The issuing bodies pursuing pharmaceutical procurement span state health and human services agencies, county public health departments, and cooperative purchasing alliances serving multiple jurisdictions. Recent opportunities include Seminole County, Florida (IFB for naloxone and drug deactivation systems, due July 26, 2023), the Texas Health and Human Services Commission (RFI for direct-to-manufacturer prescription programs, issued April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and participating state and local facilities (RFP for generic pharmaceuticals and OTC products, due March 26, 2026). Geographic activity appears concentrated in Florida, Texas, and the upper Midwest, though MMCAP's multi-state structure and scope suggest broader distribution. Without recent opportunities specifically tagged to hypnotic barbiturates, assessment of pursuit viability under this code is not supported by current market signals.